psoriasis glp 1 Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1
Pay in 4 interest-free payments of $5.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![psoriasis glp 1 Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1](https://cdn.sanity.io/images/0vv8moc6/dermatologytimes/8e282d6f45124a8e8c8f0c4db3aaf85d6cbcac1b-4058x2848.jpg)
![psoriasis glp 1 Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1](https://cdn.sanity.io/images/0vv8moc6/hcplive/23bf7b6313af1026d6a83ab5eaf2193fe98203b2-1200x628.png)
![psoriasis glp 1 Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1](https://psoriasiscouncil.org/wp-content/uploads/2025/05/Exploring-the-Role-of-GLP-1-Agonists-in-Psoriasis-Treatment.png)
![psoriasis glp 1 Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1](https://cdn.sanity.io/images/0vv8moc6/dermatologytimes/0d192b51520d21e2d993318efe794a6b119e5730-5824x3264.jpg)























